Related Experiment Video
Updated: Feb 10, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
BEACON: predicting side effects and therapeutics outcomes to drugs by Bridging knowlEdge grAph with CONtextual
Chengqi Xu1,2,3, Jiaqi Xu4, Krishna C Bulusu5,6
1Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
Abstract:
Biomedical knowledge graphs encode millions of relationships between drugs, proteins, pathways, and diseases, yet translating this structured knowledge into accurate predictions remains challenging. Existing deep learning approaches, including graph neural networks and knowledge graph embeddings, assign fixed representations to entities regardless of biological context, limiting their ability to capture how the same gene or pathway functions differently across scenarios. These methods also lack interpretability and often fail when applied to novel drugs outside their training distribution. Here we present BEACON (Bridging knowlEdge grAph with CONtextual language model), a framework that transforms knowledge graphs into contextual sentence representations processable by language models. BEACON converts biomedical entities into tokens and relationships into syntactic dependencies, creating "sentence trees" that preserve graph structure while enabling contextual processing. A visibility matrix ensures that attention patterns respect the underlying knowledge graph topology, and a perturbation-based evaluation module identifies the specific genes, enzymes, and pathways driving each prediction. We demonstrate BEACON's versatility through two clinically important applications. For drug sensitivity prediction in cancer cell lines, BEACON achieves 0.941 AUROC and Spearman ρ = 0.919, outperforming existing methods (DrugCell, DeepCDR and DeepTTA). For drug-drug interaction (DDI) prediction, BEACON achieves 0.964 AUROC on the TwoSIDES benchmark and 0.84 AUROC on temporally held-out FDA adverse event data (2013-2023), demonstrating robust generalization to newly approved drugs. Applying BEACON to the BTK inhibitor acalabrutinib revealed that predicted interactions are enriched for drugs metabolized by CYP3A enzymes (OR = 3.01, P = 4.3 × 10-4), a mechanism validated through network proximity analysis. BEACON provides a unified, interpretable approach to knowledge graph-enhanced biomedical prediction.
More Related Videos
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
06:33Decomposing the Variance in Reading Comprehension to Reveal the Unique and Common Effects of Language and Decoding
Published on: October 11, 2018
Related Concept Videos
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Predicting Reaction Outcomes
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Language
Corballis and Suddendorf (2007) and Tomasello and Rakoczy (2003) highlight the role of language in...
Design Example: Strain Gauge Bridge or Wheatstone Bridge